Company intelligence / Profile preview

HiCura Medical

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

HiCura Medical is developing and clinically validating uSINE, an AI-powered ultrasound image analysis platform to guide anesthesiologists in identifying the epidural space for needle insertion. The first clinical trial is set to validate its use in patients with BMI >35 and has not yet started recruitment as of March 2025. No published clinical results are available yet.

Therapeutic areas: OtherWomen's Health
Modalities: DeviceArtificial intelligence (AI)-enabled medical device
Industry: Medical Imaging

Beyond the preview

Go deeper on HiCura Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HiCura Medical.

Explore the full profile